Ss Innovations International Inc's ability to collect accounts receivable sequentially worsen to 3.55, pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Ss Innovations International Inc's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 103 days, from 64 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 458 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 2045 to 2378.

What is Receivable Turnover Ratio?
What is Ss Innovations International Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AVMR Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) II. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	6650.63 %	135.26 %	2171.63 %	34.55 %	-93.6 %
Y / Y Revenue Change	39.39 %	11.01 %	76.54 %	192.47 %	174.91 %
Receivable Turnover Ratio (TTM)	3.55	5.72	7.35	11.86	10.8
AVMR's Total Ranking	# 2378	# 2045	# 1063	# 1163	# 2512
Accounts Receivable average collection period days	103	64	50	31	34
Seq. Receivable Change	81.42 %	13.36 %	79.25 %	1731.36 %	-93.68 %
Seq. Revenue Change	25.57 %	-22.52 %	11.68 %	28.29 %	-0 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 166
Healthcare Sector	# 459
Overall Market	# 2378

Receivable Turnover Ratio Statistics
High	Average	Low
11.86	4.94	0.02
(Sep 30 2025)		(Dec 31 2019)

AVMR Company Profile • Back to AVMR Efficiency Comparisons • Compare AVMR Receivables Turnover Ratio to its Competitors

Financial Statements
Ss Innovations International Inc's Accounts Receivable	$ 25 Millions	Visit AVMR's Balance sheet
Ss Innovations International Inc's Sales TTM	$ 52 Millions	Visit AVMR's Income Statement
Sources of AVMR's Revenues		Visit AVMR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AVMR's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AVMR's Growth Rates	AVMR's Roa	AVMR's Inventory Turnover Ratio	AVMR's Dividend Comparisons
AVMR's Profitability Ratios	AVMR's Roi	AVMR's Asset Turnover Ratio	AVMR's Dividend Growth
AVMR's Valuation Ratios	AVMR's Roe	AVMR's Financial Strength Ratios	AVMR's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Community Health Systems Inc	5.63	$ 11,983.000 Millions	$ 2,129.500 Millions
Surgery Partners Inc	5.61	$ 3,366.300 Millions	$ 600.375 Millions
Bioxcel Therapeutics Inc	5.59	$ 0.742 Millions	$ 0.133 Millions
Integer Holdings Corporation	5.57	$ 1,842.621 Millions	$ 330.687 Millions
Intelligent Bio Solutions Inc	5.51	$ 4.215 Millions	$ 0.765 Millions
Johnson and Johnson	5.47	$ 97,929.000 Millions	$ 17,889.000 Millions
Merck and Co Inc	5.47	$ 66,569.000 Millions	$ 12,167.250 Millions
Quanterix Corporation	5.45	$ 152.716 Millions	$ 28.030 Millions
Brightspring Health Services Inc	5.45	$ 5,877.918 Millions	$ 1,079.324 Millions
Charles River Laboratories International inc	5.44	$ 3,998.987 Millions	$ 734.654 Millions
Rigel Pharmaceuticals Inc	5.43	$ 276.785 Millions	$ 50.994 Millions
Blue Water Vaccines Inc	5.42	$ 0.646 Millions	$ 0.119 Millions
Igc Pharma Inc	5.36	$ 1.101 Millions	$ 0.206 Millions
Strata Critical Medical Inc	5.27	$ 211.642 Millions	$ 40.126 Millions
Karyopharm Therapeutics Inc	5.27	$ 146.621 Millions	$ 27.821 Millions
Elutia Inc	5.16	$ 11.353 Millions	$ 2.198 Millions
West Pharmaceutical Services Inc	5.12	$ 3,326.900 Millions	$ 649.250 Millions
Repligen Corp	5.09	$ 785.101 Millions	$ 154.205 Millions
Progyny Inc	5.09	$ 1,311.298 Millions	$ 257.570 Millions
Pfizer Inc	4.98	$ 63,696.000 Millions	$ 12,802.250 Millions
Stereotaxis Inc	4.98	$ 29.892 Millions	$ 6.008 Millions
Invivyd Inc	4.96	$ 58.365 Millions	$ 11.776 Millions
Agilent Technologies inc	4.96	$ 7,372.000 Millions	$ 1,487.500 Millions
Plus Therapeutics Inc	4.90	$ 4.203 Millions	$ 0.858 Millions
Abeona Therapeutics Inc	4.83	$ 30.093 Millions	$ 6.232 Millions
Ligand Pharmaceuticals Incorporated	4.77	$ 290.542 Millions	$ 60.966 Millions
Personalis Inc	4.75	$ 69.669 Millions	$ 14.676 Millions
Bausch and Lomb Corp	4.65	$ 5,324.000 Millions	$ 1,144.000 Millions
Davita Inc	4.64	$ 14,009.646 Millions	$ 3,018.719 Millions
Staar Surgical Co	4.63	$ 339.590 Millions	$ 73.350 Millions

Date modified: 2026-09-03T11:32:11+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.